Literature DB >> 16054517

Detection of mutations in whole genome-amplified DNA from laser-microdissected neurons.

Roger Pamphlett1, Paul R Heath, Hazel Holden, Paul G Ince, Pamela J Shaw.   

Abstract

Laser microdissection allows removal of individual cells for DNA extraction, but obtaining reliably amplified DNA from the small numbers of cells that survive neurodegenerative diseases can be difficult. We therefore tested a recently-available technique to amplify genomic DNA to see if it could reliably detect a mutation in nervous system cells. Fifty cortical motor neurons were removed by laser microdissection from cases of motor neuron disease both with and without known mutations in the gene for superoxide dismutase 1 (SOD1). DNA was extracted and amplified with a linear genomic amplification kit (GenomiPhitrade mark). The PCR product of exon 4 of SOD1 from this DNA was then sequenced. The GenomiPhi kit amplified the extracted DNA approximately 70 times. When exon 4 of SOD1 from this DNA was amplified by PCR the E100G SOD1 mutation could be identified on sequencing. No errors in replication were found. In conclusion, the GenomiPhi method of genomic DNA amplification appears to result in reliable replication of mutations in neurons. This technique can be used to obtain increased amounts of genomic DNA to study mutations within cells of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054517     DOI: 10.1016/j.jneumeth.2005.03.005

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  2 in total

Review 1.  The role of de novo mutations in adult-onset neurodegenerative disorders.

Authors:  Gaël Nicolas; Joris A Veltman
Journal:  Acta Neuropathol       Date:  2018-11-26       Impact factor: 17.088

2.  Amplification of multiple genomic loci from single cells isolated by laser micro-dissection of tissues.

Authors:  Dan Frumkin; Adam Wasserstrom; Shalev Itzkovitz; Alon Harmelin; Gideon Rechavi; Ehud Shapiro
Journal:  BMC Biotechnol       Date:  2008-02-20       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.